Ptc Therapeutics PTCT Cash Flow Statement (2012-2026)

NASDAQ PTCT
$69.75 -1.65 (-2.30%)
As of: Sep 4, 2026 · 2:22 PM EDT
Reported Financials

Ptc Therapeutics Quarterly Cash Flow Statement

Periods 57 quarters
Latest Jun 2026

Ptc Therapeutics reported cash from operations of $129.11M and free cash flow of $126.92M for the quarter ended Jun 2026, up 321.3% year over year. This cash flow statement covers 57 quarters of results from Jun 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-133.62M-143.26M-126.73M-152.09M-109.31M-174.53M-138.96M-198.88M-132.97M-244.43M-91.58M-99.18M-106.65M-328.20M866.56M-64.85M15.90M285.92M-2.81M83.50M
Share-based CompensationStock Comp.
25.87M26.24M26.59M27.73M28.67M27.34M28.82M29.37M26.94M18.38M19.24M19.75M17.24M18.06M18.54M137.20M18.52M231.70M206.80M
Deferred Taxes
-0.00M-50.90M-0.00M3.98M-0.00M0.00M-0.00M-55.91M0.00M0.00M-0.01M
Gains from Investment SecuritiesGains Investment
10.80M-12.10M-11.70M-15.20M-5.30M6.30M2.40M-128.90M1.50M-2.70M-0.10M5.10M0.70M-10.18M-0.80M
Asset Writedowns and ImpairmentWritedown
217.80M0.20M1.30M158.06M0.10M0.40M0.50M
Cash from OperationsCash from Ops.
-51.19M-68.84M-97.40M-55.24M-38.05M-165.96M-29.49M-14.12M-14.52M-100.29M70.76M-71.45M-76.99M-30.00M870.10M-58.33M-66.30M-34.27M-59.04M129.11M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
1.85M1.87M1.91M2.39M3.21M2.38M2.94M2.73M2.48M1.67M3.70M3.30M2.95M2.58M2.31M4.56M6.10M5.05M4.11M4.16M
Amortization of Deferred ChargesAmort. Deferred Charges
0.28M0.47M0.46M0.28M0.29M0.58M0.44M0.29M0.29M0.30M0.30M0.29M0.30M0.31M0.30M0.30M0.31M0.31M0.30M0.27M
Depreciation & Amortization (CF)Dep. & Amort.
16.75M18.81M26.31M29.18M34.48M38.87M42.83M51.01M62.05M80.70M55.40M7.02M6.49M6.76M7.22M7.58M11.11M12.90M15.41M15.87M
Change in Working Capital
Change in ReceivablesChange Receivables
19.20M16.37M28.37M1.18M-4.78M23.70M43.43M-25.40M-8.13M-8.35M39.50M-8.19M7.72M-40.76M47.79M-21.90M6.47M-22.21M40.39M19.73M
Change in InventoryChange Inventory
-0.57M0.68M-0.35M0.32M0.80M5.90M4.61M5.18M4.33M-5.94M-0.12M1.94M3.11M-11.09M-2.19M10.78M18.53M26.78M-2.64M15.86M
Change in Accured ExpensesChange Accured Exp.
18.11M36.77M-30.68M21.62M10.63M25.97M33.52M-1.09M8.00M7.91M5.98M-24.69M13.97M-28.59M18.50M-35.82M-19.02M108.08M-68.71M37.50M
Other Working Capital ChangesOther WC Changes
0.03M0.04M-1.14M-0.21M1.22M-0.42M-0.80M5.72M7.20M-3.35M-8.14M0.30M-1.52M0.72M
Investing Activities
Capital ExpendituresCapex
5.84M8.73M9.31M8.70M5.38M8.62M10.27M6.25M6.36M5.57M9.59M-7.38M0.52M3.77M1.72M1.25M3.52M2.37M1.20M2.19M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.02M0.07M
Acquisitions
Change in Acquisitions & DivestmentsChange Acquisitions
0.70M150.18M167.10M1.20M100.80M63.24M12.50M2.21M7.83M110.68M61.65M19.37M21.05M258.77M136.75M8.23M22.98M359.55M376.36M27.61M
Cash from Investing ActivitiesCash from Investing
64.70M68.27M49.04M72.25M136.44M32.44M-28.97M-23.75M-29.60M-94.42M-114.93M-65.92M-42.67M267.71M-184.36M-422.01M-289.62M34.01M-93.74M-122.56M
Financing Activities
Other financing activitiesOther financing
2.98M1.19M2.44M0.75M10.01M36.80M5.66M14.67M3.45M976.23M2.03M241.80M-2.04M15.75M1.13M16.83M206.28M6.40M13.23M
Cash from Financing ActivitiesCash from Financing
2.98M4.35M1.17M3.86M-140.00M302.92M4.09M18.46M3.36M620.49M0.54M246.48M-17.63M26.47M9.41M3.96M15.22M302.50M6.40M211.88M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
2.49M1.28M1.69M0.86M2.20M0.86M1.26M0.80M0.85M0.75M
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Exchange Rate EffectFX Effect
-4.02M-3.89M1.65M1.69M-12.14M6.02M-7.96M10.31M-2.33M3.10M-2.03M-5.19M8.54M-8.65M5.39M13.59M-6.06M9.79M-1.52M-2.54M
Change in Cash
12.47M-0.10M-45.54M22.57M-53.73M175.41M-62.33M-9.10M-43.09M428.87M-45.66M103.92M-128.75M255.53M700.55M-462.79M-346.77M312.03M-147.90M215.90M
Free Cash FlowFCF
-57.03M-77.57M-106.72M-63.94M-43.43M-174.59M-39.76M-20.36M-20.88M-105.85M61.17M-64.08M-77.51M-33.77M868.38M-59.58M-69.82M-36.65M-60.24M126.92M
Net Cash FlowNCF
16.49M3.79M-47.19M20.87M-41.59M169.39M-54.37M-19.41M-40.75M425.78M-43.63M109.11M-137.29M264.18M695.15M-476.38M-340.70M302.24M-146.38M218.44M